Navigation Links
Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer

amous cell carcinoma of the head and neck for whom prior platinum-based therapy has failed.

ERBITUX is indicated for the treatment of EGFR-expressing, metastatic colorectal carcinoma (mCRC) in combination with irinotecan for patients who are refractory to irinotecan-based chemotherapy, and as a single agent for patients who are intolerant to irinotecan-based therapy. The effectiveness of ERBITUX for the treatment of EGFR-expressing mCRC cancer is based on objective response rates. Currently, no data are available that demonstrate an improvement in disease-related symptoms or increased survival with ERBITUX for the treatment of EGFR-expressing mCRC.

For full prescribing information, including boxed WARNINGS regarding infusion reactions and cardiopulmonary arrest, visit http://www.ERBITUX.com.

Grade 3/4 infusion reactions, rarely with fatal outcome (<1 in 1000), occurred in approximately 3% (46/1485) of patients receiving ERBITUX (Cetuximab) therapy. These reactions are characterized by rapid onset of airway obstruction (bronchospasm, stridor, hoarseness), urticaria, hypotension, and/or cardiac arrest. Severe infusion reactions require immediate and permanent discontinuation of ERBITUX therapy.

Most reactions (90%) were associated with the first infusion of ERBITUX despite the use of prophylactic antihistamines. Caution must be exercised with every ERBITUX infusion as there were patients who experienced their first severe infusion reaction during later infusions. A 1-hour observation period is recommended following the ERBITUX infusion. Longer observation periods may be required in patients who experience infusion reactions.

Cardiopulmonary arrest and/or sudden death occurred in 2% (4/208) of patients with squamous cell carcinoma of the head and neck treated with radiation therapy and ERBITUX as compared to none of 212 patients treated with radiation therapy alone. Fatal events o
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Positive Results Prompt US National Cancer Institute to Make Glivec Available to Patients in Post-Surgical GIST Study
3. Positive Results Prompt US National Cancer Institute to Make Gleevec Available To Patients in Post-Surgical Gist Study
4. Survival Data Available From Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer
5. Survival Data Available from Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer
6. Extensive Clinical Data on Erbitux Presented at the 2007 ASCO Annual Meeting
7. Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
8. Randomized Phase III Trial Showed Erbitux Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients
9. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:7/24/2014)... Many new dentists who are opening their own ... their practice will be a success. DentalDisposables.net is here to ... the most can make all the difference. Dentistry is a ... that purchasing discount dental supplies can make the ... successful dentists across the United States ...
(Date:7/24/2014)... , July 24, 2014  Kinex Pharmaceuticals announced the ... the Company,s KX2-391 Ointment for the commencement of a ... the Company,s third IND to be allowed by the ... KX2-391 is a synthetic, orally active and highly selective ... KX2-391 promotes the induction of p53, G2/M arrest of ...
(Date:7/24/2014)... 2014 Research and Markets  has announced ... by Product, Component, Application and Geography - Global Forecast ... http://photos.prnewswire.com/prnh/20130307/600769 ... witness a moderate growth as the markets of the ... reached the saturation levels. The demand is expected to ...
Breaking Medicine Technology:Dental Supplies Online is Key to Dental Success...Really! 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4Machine Health Monitoring (Vibration Monitoring, Thermography, Ultrasound Emission, Lubricating Oil Analysis, Corrosion Monitoring, Motor Current Signature Analysis) Market - Forecast to 2020 2
(Date:7/24/2014)... Dr. Henry H. Ting, a nationally recognized ... appointed senior vice president and chief quality officer at ... role, he will oversee the hospital's clinical quality and ... quality initiatives and interprofessional teams at the local, regional ... Door-to-Balloon Alliance, a collaboration of more than 1,000 hospitals ...
(Date:7/24/2014)... breast tumors, exposure to dim light at night made ... according to data published in Cancer Research , ... The negative effects of dim light exposure on tamoxifen ... during the night. , "Resistance to tamoxifen is a ... said Steven M. Hill, PhD, professor of structural and ...
(Date:7/24/2014)... 25, 2014 Voted one of the ... global clients, BellasDress focuses on providing its new and ... information. Recently, the company has announced its new collection ... new range is created according to the latest fashion ... up to 68% off. , As a matter of ...
(Date:7/24/2014)... The report, “Content Delivery Networks (CDN) Market”, defines ... with an in-depth analysis and forecasting of revenues. ... this market with insights on trends, opportunities, and ... 36 figures spread through 157 pages and in-depth ... http://www.marketsandmarkets.com/Market-Reports/content-delivery-networks-cdn-market-657.html . , Early buyers will ...
(Date:7/24/2014)... July 24, 2014 Just as fitness ... must consider their own financial and marketing strength to ... marketing campaigns to the next level by using the ... Center, IVR, Voice Broadcast, Call Tracking and SMS ... open rate, text messages are quickly become integral in ...
Breaking Medicine News(10 mins):Health News:NewYork-Presbyterian Hospital Names New Senior Vice President for Quality and Patient Safety 2Health News:NewYork-Presbyterian Hospital Names New Senior Vice President for Quality and Patient Safety 3Health News:Exposure to dim light at night may make breast cancers resistant to tamoxifen 2Health News:BellasDress Helps Brides Get High End Wedding Dresses for Their Romantic Weddings 2Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 2Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 3Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 2Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 3
... Short-course (DOTS) tuberculosis control programme will cover the entire country ... here Sunday.//, ,"The drugs for the DOTS programme will ... remote areas," said the minister at a function here to ... ,The facility has come up at the Tuberculosis Research ...
... In China people's attitudes toward sex has completely changed. Chinese ... (LAT). In this one can life the life of a ... does not desires to stay together and that the partner ... agreement includes that neither of them is obliged to have ...
... out that babies breastfed for six months have reduced ... research was conducted by investigators at UC Davis Children's ... of Pediatrics, Center for Child Health Research. ... UC Davis Children's Hospital, lead author, "We found that ...
... 'dead regions' in the brain that could be responsible ... Karolina Kluk, a Cambridge University student. // The finding ... aids for children. ,The currently available methods ... a range of tones or bleeps. This however, cannot ...
... birth control patch are twice as likely to develop clots in ... Recently, another study conducted on similar grounds // has revealed that ... women who use the patch have been urged to discus their ... ,Women who use the patch may be at an increased risk ...
... clinical trial of administering xenon gas to patients undergoing ... safe from // the brain damage that occurs post ... xenon gas to 12 patients undergoing CABG on cardiopulmonary ... treat patients suffering from strokes in whom brain damage ...
Cached Medicine News:Health News:Sex a commonplace in Chinese life 2Health News:New Test Offers Hope in Effective Hearing Aid Design for Babies 2Health News:Xenon Could Limit Nerve Damage After Stroke 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: